This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Laboratorios Del Dr. Esteve S.a.. Active years: 2016.
Company Filing History:
Years Active: 2016
Title: Ramon Mercè Vidal: Innovator in EP1 Receptor Ligands
Introduction
Ramon Mercè Vidal is a notable inventor based in Barcelona, Spain. He has made significant contributions to the field of medicinal chemistry, particularly in the development of EP1 receptor ligands. His work focuses on compounds that exhibit high affinity and selectivity for the EP1 receptor, which plays a crucial role in various physiological processes.
Latest Patents
Ramon Mercè Vidal holds a patent related to EP1 receptor ligands. The patent describes compounds of general formula (I) that demonstrate great affinity and selectivity for the EP1 receptor. This invention also outlines the process for preparing these compounds, their use as medicaments for treating or preventing diseases mediated by the EP1 receptor, and the pharmaceutical compositions that include them. He has 1 patent to his name.
Career Highlights
Ramon is associated with Laboratorios del Dr. Esteve S.A., where he continues to advance his research and development efforts. His work has the potential to impact the treatment of various disorders linked to the EP1 receptor, showcasing his commitment to innovation in the pharmaceutical industry.
Collaborations
Ramon has collaborated with esteemed colleagues such as Antoni Torrens Jover and Francesc Xavier Caldentey Frontera. These collaborations have likely enriched his research and contributed to the success of his projects.
Conclusion
Ramon Mercè Vidal is a distinguished inventor whose work on EP1 receptor ligands holds promise for medical advancements. His contributions to the field exemplify the importance of innovation in addressing health challenges.